We found that the GPR126 enhancer is recurrently mutated in transitional cell carcinoma of the bladder (Bladder-TCC; 14/23 samples) and breast adenocarcinoma (Breast-AdenoCA; 8/195) (Supplementary Fig. 14f). The gene discussed is ADGRG6; the disease is bladder transitional cell carcinoma.